Over the last 15 years, the treatment of infrarenal aortic aneurysms has dramatically changed. Today, about 50% of patients with abdominal aortic aneurysms are treated endoluminally. These patients have been treated with a variety of devices. As long-term follow-up continues, considerable evidence has accumulated regarding the prevention and treatment of endovascular graft complications, with migration and proximal attachment failure as the most serious and significant. This article reviews risk factors and strategies for the prevention and treatment of short- and long-term graft migration and proximal attachment graft failure, including appropriate patient and graft selection and accurate graft deployment.
|Number of pages||4|
|Journal||Vascular Disease Management|
|State||Published - Jul 1 2006|